The Efficacy and Safety of Cerebrolysin on Functional Outcomes in Acute Ischemic Stroke: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials (P7-4.011) | Synapse
June 13, 2026
The Efficacy and Safety of Cerebrolysin on Functional Outcomes in Acute Ischemic Stroke: An Updated Systematic Review and Meta-analysis of Randomized Controlled Trials (P7-4.011)
Key Points
This review aims to assess the effects of cerebrolysin on functional recovery in acute ischemic stroke patients.
Conducted a systematic review and meta-analysis of randomized controlled trials.
Focused on functional outcomes related to cerebrolysin treatment in acute ischemic stroke patients.
Cerebrolysin showed significant improvements in functional outcomes compared to control groups, with higher recovery rates.
No major safety concerns were reported, indicating a favorable safety profile.
Abstract
This systematic review and meta-analysis aim to investigate the improvements in functional outcomes with cerebrolysin in patients suffering from acute ischemic stroke.